Evidence method
Level · gp.fundamentals.capex_revenue_ratio
8.61% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Sep 30, 2017
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-17-000050General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.04% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.shares_outstanding
1.46% · CORE · VALID
Evidence method
Yoy · gp.fundamentals.revenue
5.71% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
54.19% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
31.39% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
16.05% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.29% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.16% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 7.42%
- Current
- 8.61%
- Delta
- 1.19%
- Previous
- 21.45%
- Current
- 19.04%
- Delta
- -2.42%
- Previous
- 1.07%
- Current
- 1.46%
- Delta
- 0.39%
- Previous
- 2.47%
- Current
- 5.71%
- Delta
- 3.23%
- Previous
- 53.14%
- Current
- 54.19%
- Delta
- 1.05%
- Previous
- 31.44%
- Current
- 31.39%
- Delta
- -0.05%
- Previous
- 10.74%
- Current
- 16.05%
- Delta
- 5.31%
- Previous
- 2.52%
- Current
- 2.29%
- Delta
- -0.23%
- Previous
- 1.38%
- Current
- 1.16%
- Delta
- -0.23%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Transitioned To · WST Fundamental State →Transitioned To · WST CAPEX_INTENSITY_INCREASED →Transitioned To · WST CASH_GENERATION_DECREASED →Transitioned To · WST DILUTION_INCREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_INCREASED →Transitioned To · WST MARGIN_DECREASED →Transitioned To · WST PROFITABILITY_INCREASED →Transitioned To · WST R_AND_D_INTENSITY_DECREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.